The story behind the revolutionary new test to assess prostate cancer risk
Screening associated with greater prostate cancer survival benefit
A Prostate Health Education Network video presented by Dr. Todd Cohen
Data confirm decades-old hypothesis that metastatic disease hijacks tissue-specific developmental programs.
Expanded research program and revolutionary, inexpensive, non-invasive test to assess genetic risk of prostate cancer is now in development
Black patients could also benefit from recently approved PARP therapies.